title: A paradigm shift in the treatment of atherosclerosis.
authors.affiliation: Department of Cardiology, Toulouse University School of Medicine, Rangueil Hospital, TSA 50032, 31059 Toulouse cedex 9, France. Electronic address: jean.ferrieres@univ-tlse3.fr.
authors.forename: Jean
authors.initials: J
authors.lastname: Ferrières
mesh_terms: D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D008078:Cholesterol, LDL / Q000097:blood; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D000069438:Ezetimibe / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008019:Life Style; D015337:Multicenter Studies as Topic; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D019851:Thrombophilia / Q000188:drug therapy / Q000209:etiology
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D000069438:Ezetimibe
keywords: Atherosclerosis; Athérosclérose; Cholesterol; Cholestérol; Ezetimibe; Guidelines; Recommandations; Statin; Statine; Ézétimibe